Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

A time of great expectations

This article was originally published in Clinica

Executive Summary

The real significance of a year lies more in what it bequeathed for the next, than in the detail of its own twelve months. For the UK medical technology industry, 2003 left great expectations, most notably the promise of far-reaching initiatives to develop the industry on multiple interweaving levels. The year also sowed the seeds of institutional reforms, laying the foundations - with ironic meaning - of historic changes to the very nature of the National Health Service, writes Bernard Murphy

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT057316

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel